LRI Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$878K Buy
2,270
+355
+19% +$132K 0.07% 139
2026
Q1
$561K Sell
1,915
-84
-4% -$27.6K 0.05% 170
2025
Q4
$701K Buy
1,999
+313
+19% +$106K 0.06% 144
2025
Q3
$545K Buy
1,686
+79
+5% +$24.6K 0.04% 174
2025
Q2
$625K Sell
1,607
-62
-4% -$24.9K 0.05% 155
2025
Q1
$726K Buy
1,669
+23
+1% +$9.23K 0.07% 130
2024
Q4
$607K Sell
1,646
-15
-0.9% -$6.28K 0.06% 121
2024
Q3
$676K Buy
1,661
+55
+3% +$29.4K 0.07% 121
2024
Q2
$870K Hold
1,606
0.1% 73
2024
Q1
$833K Buy
+1,606
New +$799K 0.21% 55

Other funds holding ELV

LRI Investments's ELV Position: Q2 2026 in Review

LRI Investments increased its Elevance Health (ELV) stake by 19% in Q2 2026, buying an estimated $132K and bringing the position to 2,270 shares worth $878K. The position accounts for 0.07% of the portfolio, ranked #139.

LRI Investments first reported a position in ELV in Q1 2024 and has held it in 10 quarters since. 615 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • LRI Investments held 2,270 shares of Elevance Health worth $878K as of Q2 2026.
  • LRI Investments bought 355 Elevance Health shares in Q2 2026, an estimated $132K.
  • Elevance Health made up 0.07% of LRI Investments's portfolio in Q2 2026, its #139 holding.
  • LRI Investments first reported a position in Elevance Health in Q1 2024 and has held it in 10 quarters since.
  • 615 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.